$INZY Inozyme Pharma, Inc. Insider Trading
Get free email notifications about insider trading in Inozyme Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Inozyme Pharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Inozyme Pharma, Inc. for free.
CIK Number: 0001693011
IRS Number: 475129768
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: INZY
Company Address: 321 SUMMER STREET SUITE 400 BOSTON 02210
Phone number: 857-330-4340
Former name: Inozyme Pharma, LLC, date of change: 2016-12-22
Inozyme Pharma, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2021 | INZY | Inozyme Pharma, In ... | Bhagat Sarah M | Director | Option Exercise | A | 17.12 | 9,367 | 160,363 | 9,367 | |
Jun 24 2021 | INZY | Inozyme Pharma, In ... | DIAZ REINALDO M | Director | Option Exercise | A | 17.12 | 9,367 | 160,363 | 9,367 | |
Jun 24 2021 | INZY | Inozyme Pharma, In ... | Inozyme Pharma, Inc. | Director | Option Exercise | A | 17.12 | 9,367 | 160,363 | 9,367 | |
Mar 25 2021 | INZY | Inozyme Pharma, In ... | Basso Stephen | SVP Finance (PFO) | Option Exercise | A | 17.77 | 13,000 | 231,010 | 13,000 | |
Mar 17 2021 | INZY | Inozyme Pharma, In ... | Jungles Steven J | SVP, CTO | Option Exercise | A | 19.78 | 42,000 | 830,760 | 42,000 | |
Mar 17 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 19.78 | 117,000 | 2,314,260 | 117,000 | |
Mar 17 2021 | INZY | Inozyme Pharma, In ... | Bjarke Henric Bjorn | SVP, COO | Option Exercise | A | 19.78 | 51,000 | 1,008,780 | 51,000 | |
Mar 17 2021 | INZY | Inozyme Pharma, In ... | Basso Stephen | SVP Finance (PFO) | Option Exercise | A | 19.78 | 27,000 | 534,060 | 27,000 | |
Feb 04 2021 | INZY | Inozyme Pharma, In ... | Wenkert Deborah | SVP, CMO | Option Exercise | A | 22.61 | 100,000 | 2,261,000 | 100,000 | |
Jan 14 2021 | INZY | Inozyme Pharma, In ... | Jungles Steven J | SVP, CTO | Option Exercise | A | 2.77 | 44,315 | 122,753 | 44,315 | |
Jan 14 2021 | INZY | Inozyme Pharma, In ... | Huertas Pedro | SVP, CMO | Option Exercise | A | 2.77 | 36,074 | 99,925 | 36,074 | |
Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bjarke Henric Bjorn | SVP, COO | Option Exercise | A | 2.77 | 51,105 | 141,561 | 51,105 | |
Jan 14 2021 | INZY | Inozyme Pharma, In ... | Basso Stephen | SVP Finance (PFO) | Option Exercise | A | 2.77 | 41,794 | 115,769 | 41,794 | |
Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 16.00 | 66,788 | 1,068,608 | 66,788 | |
Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 2.77 | 159,187 | 440,948 | 159,187 |